Cancer Vaccines

Cancer Vaccine Data Presented at Joint FDA-NCI Workshop

Published in Cancer Weekly, December 28th, 1998

AVAX Technologies Inc., Kansas City, Missouri, announced that at the invitation of the U.S. Food and Drug Administration (FDA) it had presented an initial talk at a U.S. National Cancer Institute (NCI)-FDA sponsored workshop on the regulation of new cancer vaccines on December 11, 1998, on the campus of the U.S. National Institutes of Health (NIH) in Bethesda, Maryland.

The FDA is working to develop a regulatory framework that ensures the safety and efficacy of these vaccines, and has turned to members of academia and industry for advice. AVAX presented data obtained in its development program pertaining to the manufacture and characterization of its vaccine...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-12-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry